Dermata Therapeutics, Inc.
DRMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001853816
No open-market purchases or sales by Dermata Therapeutics, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $158.0K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Dermata Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −2 vs. Q2 2022
- Shares held
- 197.2K
- −656.7K (−76.9%) vs. Q2 2022
- Total value
- $101.0K
- −$453.0K (−81.8%) vs. Q2 2022
- New holders
- 3
- 2 more added
- Sold out
- 5
- 1 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DRMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $158.0K |
| Q1 2026 | 7 | $128.9K |
| Q4 2025 | 7 | $62.4K |
| Q3 2025 | 5 | $463.0K |
| Q2 2025 | 10 | $297.5K |
| Q1 2025 | 8 | $561.2K |
| Q4 2024 | 6 | $61.5K |
| Q3 2024 | 4 | $10.6K |
| Q2 2024 | 6 | $78.3K |
| Q1 2024 | 7 | $29.8K |
| Q4 2023 | 6 | $184.8K |
| Q3 2023 | 6 | $110.1K |
| Q2 2023 | 8 | $236.3K |
| Q1 2023 | 4 | $47.4K |
| Q4 2022 | 11 | $118.8K |
| Q3 2022 | 9 | $101.0K |
| Q2 2022 | 11 | $554.0K |
| Q1 2022 | 8 | $91.0K |
| Q4 2021 | 11 | $226.0K |
| Q3 2021 | 8 | $1.19M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Dermata Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtu Financial LLC | 70,808 | $37.0K | 0.00% | +70,808 | New |
| Geode Capital Management, LLC | 26,666 | $13.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 24,418 | $13.0K | 0.00% | +13,395+121.5% | Added |
| Jane Street Group, LLC | 23,565 | $12.0K | 0.00% | +23,565 | New |
| UBS Group AG | 14,798 | $8.00K | 0.00% | +3,591+32.0% | Added |
| Sage Capital Advisors,llc | 12,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tudor Investment Corp Et Al | 10,205 | $5.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 10,000 | $5.00K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 4,772 | $2.00K | 0.00% | −22−0.5% | Reduced |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −637,147−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −79,969−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −48,942−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,496−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |